Quest Diagnostics price target raised to $178 from $177 at Mizuho
Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $178 from $177 and keeps an Outperform rating on the shares following the ...
Quest Diagnostics price target raised to $180 from $165 at Piper Sandler
Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...
Earnings call transcript: Quest Diagnostics Q4 2024 beats EPS forecast
Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...
Quest Diagnostics: Q4 Earnings Snapshot
On a per-share basis, the Secaucus, New Jersey-based company said it had profit of $1.95. Earnings, adjusted for one-time gains and costs, came to $2.23 per share. The results exceeded Wall Street ...
Quest beats quarterly estimates on strong diagnostic test demand
Laboratory operator Quest Diagnostics beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by a robust appetite for its diagnostic tests.
Organ Transplant Diagnostics Market Size to Surpass USD 12.57 Billion by 2033 | Straits Research
The global organ transplant diagnostics market size was valued at USD 4.95 billion in 2024 and is projected to reach from USD ...